Healthequity (NASDAQ:HQY) Releases Q2 Earnings Guidance

Healthequity (NASDAQ:HQY) issued an update on its second quarter earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $0.23 for the period, compared to the Thomson Reuters consensus estimate of $0.45. The company issued revenue guidance of $168-$173 million, compared to the consensus revenue estimate of $191.51 million.Healthequity also updated its Q2 2021
After-Hours guidance to 0.23-0.30 EPS.

NASDAQ:HQY traded up $0.44 during mid-day trading on Tuesday, reaching $62.61. The company’s stock had a trading volume of 1,013,627 shares, compared to its average volume of 949,985. Healthequity has a 12-month low of $34.40 and a 12-month high of $88.78. The firm’s fifty day moving average price is $53.76 and its two-hundred day moving average price is $62.71. The company has a current ratio of 1.96, a quick ratio of 1.96 and a debt-to-equity ratio of 1.21. The stock has a market cap of $4.42 billion, a P/E ratio of 96.32, a PEG ratio of 2.50 and a beta of 1.46.

Healthequity (NASDAQ:HQY) last issued its earnings results on Monday, March 16th. The company reported $0.39 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.23 by $0.16. Healthequity had a return on equity of 10.54% and a net margin of 7.46%. The business had revenue of $201.20 million during the quarter, compared to analyst estimates of $199.95 million. During the same quarter in the previous year, the firm earned $0.21 EPS. Healthequity’s revenue was up 165.4% on a year-over-year basis. Analysts predict that Healthequity will post 1.25 earnings per share for the current fiscal year.

Several research firms have recently commented on HQY. Barrington Research reaffirmed a buy rating and set a $65.00 price target on shares of Healthequity in a research report on Monday. Deutsche Bank reduced their price target on shares of Healthequity from $88.00 to $57.00 and set a buy rating for the company in a research report on Wednesday, March 18th. SVB Leerink began coverage on shares of Healthequity in a research report on Monday, April 13th. They set a market perform rating and a $53.00 price target for the company. Cantor Fitzgerald reaffirmed a buy rating and set a $80.00 price target on shares of Healthequity in a research report on Monday, April 20th. Finally, Raymond James reduced their price target on shares of Healthequity from $90.00 to $75.00 and set a strong-buy rating for the company in a research report on Wednesday, April 8th. One analyst has rated the stock with a sell rating, five have issued a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. Healthequity currently has an average rating of Buy and a consensus target price of $67.67.

In other Healthequity news, CEO Jon Kessler sold 100,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $62.59, for a total value of $6,259,000.00. Following the completion of the transaction, the chief executive officer now directly owns 405,715 shares in the company, valued at approximately $25,393,701.85. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 3.70% of the company’s stock.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Story: Cost of Equity

Earnings History and Estimates for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.